Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALPHAMAB-B

10.080
+0.0200.20%
Volume:1.44M
Turnover:14.33M
Market Cap:9.78B
PE:53.25
High:10.150
Open:9.850
Low:9.580
Close:10.060
52wk High:15.750
52wk Low:3.050
Shares:970.00M
HK Float Shares:970.00M
Volume Ratio:0.96
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.189
ROE:13.37%
ROA:5.22%
PB:4.81
PE(LYR):53.25
PS:11.36

Loading ...

Alphamab Oncology (SEHK:9966): Evaluating Valuation Following Recent Pullback and Strong Year-to-Date Gains

Simply Wall St.
·
Oct 27

ALPHAMAB-B (09966) Grants 1,990,200 Shares as Incentive

Stock News
·
Oct 24

Alphamab Oncology (9966) Announces Grant of 1,990,176 Award Shares Under Restricted Share Award Scheme

Bulletin Express
·
Oct 24

BRIEF-Alphamab Oncology says Jskn003 Granted Breakthrough Therapy Designation For Her2+ Advanced CRC

Reuters
·
Oct 20

ALPHAMAB-B (09966): JSKN003 Secures Breakthrough Therapy Designation from CDE

Stock News
·
Oct 20

Alphamab Oncology (9966) Announces Second Breakthrough Therapy Designation for JSKN003

Bulletin Express
·
Oct 20

Alphamab Oncology (9966) Presents JSKN003 Clinical Advancements at ESMO 2025

Bulletin Express
·
Oct 20

Alphamab Oncology and Shanghai JMT-Bio Secure Breakthrough Therapy Designation for JSKN003 in HER2+ Advanced Colorectal Cancer

Reuters
·
Oct 20

Alphamab Oncology Presents Positive JSKN003 Clinical Trial Updates at ESMO 2025

Reuters
·
Oct 20

Alphamab Oncology - Granted by Center for Drug Evaluation of Nmpa

THOMSON REUTERS
·
Oct 20

Alphamab Oncology - Jskn003 Granted Breakthrough Therapy Designation for Her2+ Advanced Crc

THOMSON REUTERS
·
Oct 20

ALPHAMAB-B (09966): Latest Research Results of KN026's Phase III Clinical Trial Presented at 2025 ESMO Congress

Stock News
·
Oct 17

Alphamab Oncology (9966) and CSPC Pharmaceutical (1093) Announce Positive Phase III KN026 Data at ESMO 2025

Bulletin Express
·
Oct 17

Alphamab Oncology Announces Positive Phase III Trial Results for KN026 in HER2+ Gastric Cancer at ESMO Congress 2025

Reuters
·
Oct 17

ALPHAMAB-B Sees Over 14% Surge Before Noon as Market Awaits Key Data from ESMO Conference

Deep News
·
Oct 17

HK Movers | Biomedical Stocks Jump Again With TransThera Sciences up 30%

Tiger Newspress
·
Oct 17

Hong Kong Stock Buyback Statistics | October 17

Stock News
·
Oct 17

ALPHAMAB-B (09966) Repurchases 400,000 Shares for HKD 5.483 Million on October 16

Stock News
·
Oct 16

Alphamab Oncology files next day disclosure return to HKEX announcing repurchase of 400000 shares at HKD 137074 per share

Reuters
·
Oct 16

While shareholders of Alphamab Oncology (HKG:9966) are in the black over 1 year, those who bought a week ago aren't so fortunate

Simply Wall St.
·
Oct 15